At 12.3% CAGR, Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market is Projected to be worth US$ 613.75 million by 2031, says Business Market Insights

According to Business Market Insights' research, the Middle East & Africa electronic patient-reported outcomes (ePROS) market was valued at US$ 23.79 million in 2023 and is expected to reach US$ 60.23 million by 2031, registering a CAGR of 12.3% from 2023 to 2031. Emerging applications of electronic patient-reported outcomes (ePROS) and increasing focus on patient-centered care are among the critical factors attributed to drive the Middle East & Africa electronic patient-reported outcomes (ePROS) market growth.

The emerging applications of electronic patient-reported outcomes (ePRO) drive the market. The new uses of ePRO systems in decentralized clinical trials, remote patient monitoring, and other areas are stimulating innovation and extending the use of patient-reported outcomes in various healthcare, research, and clinical settings. The adoption of ePRO systems is driven by decentralized clinical trials (DCTs) growth. Patients can participate in DCTs remotely from the comfort of their homes, and ePRO tools are widely used for collecting patient-reported data immediately. The transition to virtual trials improves patient recruitment and retention, lowers the need for in-person visits, and increases trial efficiency of various diseases, including rare diseases, across geographically dispersed populations. In addition, the players are making strategic developments to meet the customers' needs. For instance, in June 2023, uMotif, a clinical trial technology company, and Syneos Health, an integrated biopharmaceutical solution company, announced a strategic partnership. By developing a more effective, end-to-end digital platform with electronic solid clinical outcome assessment (eCOA) and electronic patient-reported outcomes (ePRO) capabilities-this partnership helped accelerate clinical trials and expedite the delivery of new therapies to patients.

On the flip side , the data privacy and security issues hampers the growth of Middle East & Africa electronic patient-reported outcomes (ePROS) market.

By delivery mode, the Middle East & Africa electronic patient-reported outcomes (ePROS) market is segmented into cloud based and on-premises. The cloud based segment held 56.9% share of Middle East & Africa electronic patient-reported outcomes (ePROS) market share in 2023, amassing US$ 13.54 million. It is projected to garner US$ 34.18 million by 2031 to register 12.3% CAGR during 2023-2031.

In terms of application, the Middle East & Africa electronic patient-reported outcomes (ePROS) market is segmented into oncology, respiratory, and others. The oncology segment held 70.7% share of Middle East & Africa electronic patient-reported outcomes (ePROS) market share in 2023, amassing US$ 16.81 million. It is projected to garner US$ 43.26 million by 2031 to register 12.5% CAGR during 2023-2031.

By end user, the Middle East & Africa electronic patient-reported outcomes (ePROS) market is segmented into contract research organizations (CROs), pharmaceutical companies, and others. The pharmaceutical companies segment held 56.3% share of Middle East & Africa electronic patient-reported outcomes (ePROS) market share in 2023, amassing US$ 13.39 million. It is projected to garner US$ 33.19 million by 2031 to register 12.0% CAGR during 2023-2031.

Based on country, the Middle East & Africa electronic patient-reported outcomes (ePROS) market is categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 41.7% share of Middle East & Africa electronic patient-reported outcomes (ePROS) market in 2023. It was assessed at US$ 9.93 million in 2023 and is likely to hit US$ 26.77 million by 2031, registering a CAGR of 13.2% in 2023-2031.

Key players operating in the Middle East & Africa electronic patient-reported outcomes (ePROS) market are Assistek, Buddy Healthcare Ltd Oy, Castor, Clinical Ink Inc, Crucial Data Solutions, Curebase, Medable Inc, Medidata Solutions, Medrio, OpenClinica LLC, PatientIQ, Signant Health, Veeva Systems Inc, and Y-Prime LLC, among others.

• Aug-2024: Clinical Ink launched EDCXtra, an innovative Electronic Data Capture (EDC) system. EDCXtra incorporates all existing DDC functionality into a single web-based application which includes Clinical ink's industry leading electronic Clinical Outcome Assessments (eCOAs) and eConsent solutions, providing a comprehensive, all-in-one GCP compliant platform.
  
  

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com